HRS4R
Vull donar
Firma
ANNA QUIROGA-VARELA
Posició
Investigador/a Post-doctoral – R2
Investigadors/es Post-doctorals – R2

Projectes

Codi oficial: RD21/0002/0063 - EM Data inici: 01/01/2022 Data fi: 31/12/2024 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ, GARY CICERÓN ÁLVAREZ BRAVO Organisme finançador: INSTITUTO DE SALUD CARLOS III
Codi oficial: Estudio de biomarcadores moleculares neurodegeneración Data inici: 01/01/2022 Data fi: 31/12/2024 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ, GARY CICERÓN ÁLVAREZ BRAVO Organisme finançador: FRANCISCO SORIA MELGUIZO, S.A
Codi oficial: HZ16YWZ3K Data inici: 01/01/2022 Data fi: 30/06/2025 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ, GARY CICERÓN ÁLVAREZ BRAVO Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER.
Codi oficial: PI23/00517 Data inici: 01/01/2024 Data fi: 31/12/2024 Investigador/a principal: ANNA QUIROGA VARELA, LLUÍS RAMIÓ TORRENTÀ Organisme finançador: INSTITUTO DE SALUD CARLOS III
Codi oficial: COGNIPROG Data inici: 01/09/2023 Data fi: 31/08/2024 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ, GARY CICERÓN ÁLVAREZ BRAVO Organisme finançador: ASOC. ESCLEROSIS MULTIPLE ESPAÑA

Publicacions

Muñoz-San Martín M, Gómez I, Quiroga-Varela A, Gonzalez-Del Río M, Robles Cedeño R, Álvarez G, Buxó M, Miguela A, Villar LM, Castillo-Villalba J, Casanova B, Quintana E, Ramió-Torrentà L

miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 dx.doi.org/10.1212/NXI.0000000000200069
Monreal E, Fernández-Velasco JI, García-Sánchez MI, Sainz de la Maza S, Llufriu S, Álvarez-Lafuente R, Casanova B, Comabella M, Ramió-Torrentà L, Martínez-Rodríguez JE, Brieva L, Saiz A, Eichau S, Cabrera-Maqueda JM, Villarrubia N, Espiño M, Pérez-Miralles F, Montalbán X, Tintoré M, Quiroga-Varela A, Domínguez-Mozo MI, Rodríguez-Jorge F, Chico-García JL, Lourido D, Álvarez-Cermeño JC, Masjuan J, Costa-Frossard L, Villar LM

Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.

JAMA NEUROLOGY, 2023, 80, 397-403 dx.doi.org/10.1001/jamaneurol.2023.0010
Puig-Casadevall M, Álvarez-Bravo G, Varela AQ, Robles-Cedeño R, Sànchez Cirera L, Miguela A, Laguillo G, Montalban X, Hauser SL, Ramió-Torrentà L

Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report.

EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30, 3357-3361 dx.doi.org/10.1111/ene.15988
Tortosa-Carreres J, Quiroga-Varela A, Castillo-Villalba J, Piqueras-Rodríguez M, Ramió-Torrenta L, Cubas-Núñez L, Gasqué-Rubio R, Quintanilla-Bordas C, Huertas-Pons JM, Miguela A, Casanova B, Laiz-Marro B, Pérez-Miralles FC

Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithm.

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79, 104997-104997 dx.doi.org/10.1016/j.msard.2023.104997
Coll-Martinez C, Salavedra-Pont J, Buxó M, Quintana E, Quiroga-Varela A, Robles-Cedeño R, Puig M, Álvarez-Bravo G, Ramió-Torrentà L, Gich J

Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors.

Frontiers in Psychology, 2023, 14, 1163112-1163112 dx.doi.org/10.3389/fpsyg.2023.1163112
Zabalza A, Arrambide G, Otero-Romero S, Pappolla A, Tagliani P, López-Maza S, Cárdenas-Robledo S, Esperalba J, Fernández-Naval C, Martínez-Gallo M, Castillo M, Bonastre M, Resina-Salles M, Bertran J, Rodriguez-Barranco M, Carbonell-Mirabent P, Gonzalez M, Merchan M, Quiroga-Varela A, Miguela A, Gómez I, Álvarez G, Robles R, Perez Del Campo D, Queralt X, Soler MJ, Agraz I, Martinez-Valle F, Rodríguez-Acevedo B, Midaglia L, Vidal-Jordana Á, Cobo-Calvo Á, Tur C, Galan I, Castillo J, Río J, Espejo C, Comabella M, Nos C, Sastre-Garriga J, Ramió-Torrentà L, Tintoré M, Montalban X

Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?

MULTIPLE SCLEROSIS JOURNAL, 2022, 28, 1138-1145 dx.doi.org/10.1177/13524585221089540
Coll-Martinez C, Quintana E, Buxó M, Salavedra-Pont J, Gasull-Vicens L, Quiroga-Varela A, Costa-Frossard L, Villar LM, Fernández-Díaz E, Gracia J, Aladro Y, Méndez-Burgos A, Cerezo M, Ramió-Torrentà L, Gich J

Oligoclonal IgM bands are a promising biomarker for long-term cognitive outcomes in multiple sclerosis.

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68, 104397-104397 dx.doi.org/10.1016/j.msard.2022.104397
Merino-Galán L, Jimenez-Urbieta H, Zamarbide M, Rodríguez-Chinchilla T, Belloso-Iguerategui A, Santamaria E, Fernández-Irigoyen J, Aiastui A, Doudnikoff E, Bézard E, Ouro A, Knafo S, Gago B, Quiroga-Varela A, Rodríguez-Oroz MC

Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism.

Brain, 2022, 145, 2092-2107 dx.doi.org/10.1093/brain/awac087

Formulari de contacte

Coneix l’IDIBGI!

menu